A hospital has become the first in the country to hire a dementia research nurse to expand clinical trials, improve early ...
In the early 1980s, men and women in the prime of their lives began arriving at Walter Reed Medical Center, wrecked by a disease for which we had no name, no cause and no hope. As an infectious ...
Alzheimer's disease (AD) is a progressive neurodegenerative disorder characterized by cognitive decline such as memory loss ...
A federal quality measure intended to prevent inappropriate use of antipsychotic drugs in nursing homes is restricting access to “safe and effective treatments” for many residents with Alzheimer's and ...
A new meta-analysis of six randomized controlled trials shows that lithium supplementation does not significantly slow cognitive decline in people with mild cognitive impairment or Alzheimer’s disease ...
New research published in the journal Nature suggests that modest doses of lithium orotate may prevent or even reverse ...
Scientists have developed a new molecule that breaks down beta-amyloid plaques by binding to excess copper in the brain. The ...
Novo Nordisk is expected to announce soon whether its blockbuster GLP-1 drug semaglutide can help slow Alzheimer’s disease ...
IFLScience on MSN
The Most Devastating Symptom Of Alzheimer's Finally Has An Explanation – And, Maybe Soon, A Treatment
One of the most famous symptoms of Alzheimer's – and definitely one of the most devastating – is when patients start to ...
A new study from the University of Exeter has found that three existing medications could be repurposed to help treat or even ...
Novo Nordisk will soon announce the results of perhaps the most ambitious studies yet of its GLP-1 drug: whether it can help ...
Scientists may have found a way to stop Alzheimer’s damage before it starts — by “melting” the tiny protein clumps that are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results